| 12473323 |
Ascaroside derivatives and methods of use |
Bruce Stoltz, Corey REEVES, Eduardo J. Martinez |
2025-11-18 |
|
| 11878968 |
Aryl compounds and pharmaceutical compositions that modulate IKZF2 |
Pengyu Yang |
2024-01-23 |
|
| 11845770 |
Ascaroside derivatives and methods of use |
Brian M. Stoltz, Corey REEVES, Eduardo J. Martinez |
2023-12-19 |
$8,452,000 |
| 11123349 |
Method of treatment |
— |
2021-09-21 |
|
| 9133215 |
Macrocyclic derivatives for the treatment of diseases |
Benjamin Joseph Burke, Michael Raymond Collins, Jingrong Jean Cui, Judith Gail Deal, Robert Louis Hoffman +9 more |
2015-09-15 |
$290,120,000 |
| 8680111 |
Macrocyclic derivatives for the treatment of diseases |
Benjamin Joseph Burke, Michael Raymond Collins, Jingrong Jean Cui, Judith Gail Deal, Robert Louis Hoffman +9 more |
2014-03-25 |
$751,869,000 |
| 8119624 |
Fused phenyl amido heterocyclic compounds |
Hao Bai, Dilip Bhumralkar, Feng C. Bi, Fengli Guo, Mingying He +5 more |
2012-02-21 |
$593,520,000 |
| 7842713 |
Fused phenyl amido heterocyclic compounds |
Hao Bai, Dilip Bhumralkar, Feng C. Bi, Fengli Guo, Mingying He +5 more |
2010-11-30 |
$260,930,000 |
| 7470715 |
Estrogen modulators |
Stephen Douglas Barrett, Raj K. Raheja, Veerabahu Shanmugasundaram |
2008-12-30 |
$289,865,000 |
| 7141586 |
Nicotinamide derivatives useful as PDE4 inhibitors |
Christopher Gordon Barber, Paul Alan Glossop, Donald Middleton |
2006-11-28 |
$226,606,000 |
| 7060717 |
Nicotinamide derivatives useful as PDE4 inhibitors |
Elisabeth Colette Louise Gautier, Alan John Henderson, Thomas Victor Magee, Anthony Marfat, John Paul Mathias +3 more |
2006-06-13 |
$276,459,000 |
| 6949573 |
Nicotinamide derivatives useful as PDE4 inhibitors |
Elisabeth Colette Louise Gautier, Alan John Henderson, Thomas Victor Magee, Anthony Marfat, John Paul Mathias +3 more |
2005-09-27 |
$119,913,000 |
| 6897306 |
3-heterocyclylpropanohydroxamic acids |
Stephane Billotte, Paul Vincent Fish, Kim James, Nicholas Murray Thomson, Andrew Michael Derrick |
2005-05-24 |
$583,482,000 |
| 6821972 |
3-heterocyclylpropanohydroxamic acid PCP inhibitors |
Paul Vincent Fish, Kim James, Gavin Alistar Whitlock |
2004-11-23 |
$151,652,000 |
| 6448278 |
Procollagen C-proteinase inhibitors |
Stephane Billotte, Andrew Michael Derrick, Paul Vincent Fish, Kim James, Nicholas Murray Thomson |
2002-09-10 |
$252,411,000 |
